212 related articles for article (PubMed ID: 37058153)
1. Prognostic relevance of sarcopenia, geriatric, and nutritional assessments in older patients with diffuse large B-cell lymphoma: results of a multicentric prospective cohort study.
Pénichoux J; Lanic H; Thill C; Ménard AL; Camus V; Stamatoullas A; Lemasle E; Leprêtre S; Lenain P; Contentin N; Kraut-Tauzia J; Fruchart C; Kammoun L; Damaj G; Farge A; Delette C; Modzelewski R; Vaudaux S; Pépin LF; Tilly H; Jardin F
Ann Hematol; 2023 Jul; 102(7):1811-1823. PubMed ID: 37058153
[TBL] [Abstract][Full Text] [Related]
2. Prognostic model based on the geriatric nutritional risk index and sarcopenia in patients with diffuse large B-cell lymphoma.
Go SI; Kim HG; Kang MH; Park S; Lee GW
BMC Cancer; 2020 May; 20(1):439. PubMed ID: 32423395
[TBL] [Abstract][Full Text] [Related]
3. Clinical and prognostic role of sarcopenia in elderly patients with classical Hodgkin lymphoma: a multicentre experience.
Zilioli VR; Albano D; Arcari A; Merli F; Coppola A; Besutti G; Marcheselli L; Gramegna D; Muzi C; Manicone M; Camalori M; Ciammella P; Colloca G; Tucci A
J Cachexia Sarcopenia Muscle; 2021 Aug; 12(4):1042-1055. PubMed ID: 34114749
[TBL] [Abstract][Full Text] [Related]
4. Sarcopenia is an independent prognostic factor in elderly patients with diffuse large B-cell lymphoma treated with immunochemotherapy.
Lanic H; Kraut-Tauzia J; Modzelewski R; Clatot F; Mareschal S; Picquenot JM; Stamatoullas A; Leprêtre S; Tilly H; Jardin F
Leuk Lymphoma; 2014 Apr; 55(4):817-23. PubMed ID: 23781925
[TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of sarcopenia in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.
Go SI; Park MJ; Song HN; Kim HG; Kang MH; Lee HR; Kim Y; Kim RB; Lee SI; Lee GW
J Cachexia Sarcopenia Muscle; 2016 Dec; 7(5):567-576. PubMed ID: 27104110
[TBL] [Abstract][Full Text] [Related]
6. Combination of Sarcopenia and Anemia Predicts Worse Outcome in Elderly Patients With Diffuse Large B-Cell Lymphoma.
Liao PH; Chuang YH; Yang FS; Kuo CY; Ma MC; Liao CK; Wang MC
In Vivo; 2023; 37(4):1847-1856. PubMed ID: 37369473
[TBL] [Abstract][Full Text] [Related]
7. Sarcopenia is an independent prognostic factor in male patients with diffuse large B-cell lymphoma.
Nakamura N; Hara T; Shibata Y; Matsumoto T; Nakamura H; Ninomiya S; Kito Y; Kitagawa J; Kanemura N; Goto N; Shiraki M; Miyazaki T; Takeuchi T; Shimizu M; Tsurumi H
Ann Hematol; 2015 Dec; 94(12):2043-53. PubMed ID: 26385388
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of pretreatment skeletal muscle index and CONUT score in diffuse large B-cell Lymphoma.
Go SI; Choi BH; Park MJ; Park S; Kang MH; Kim HG; Kang JH; Jeong EJ; Lee GW
BMC Cancer; 2023 Nov; 23(1):1071. PubMed ID: 37932700
[TBL] [Abstract][Full Text] [Related]
9. Implications of Sarcopenia and Glucometabolism Parameters of Muscle Derived From Baseline and End-of-Treatment
Tan X; Sun X; Chen Y; Wang F; Shang Y; Zhang Q; Yuan H; Jiang L
Korean J Radiol; 2024 Mar; 25(3):277-288. PubMed ID: 38413112
[TBL] [Abstract][Full Text] [Related]
10. Skeletal muscle index impacts the treatment outcome of elderly patients with diffuse large B cell lymphoma.
Niiyama-Uchibori Y; Okamoto H; Miyashita A; Mizuhara K; Kanayama-Kawaji Y; Fujino T; Tsukamoto T; Mizutani S; Shimura Y; Teramukai S; Kuroda J
Hematol Oncol; 2024 Jan; 42(1):e3252. PubMed ID: 38287527
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of fat tissue loss and cachexia assessed by computed tomography scan in elderly patients with diffuse large B-cell lymphoma treated with immunochemotherapy.
Camus V; Lanic H; Kraut J; Modzelewski R; Clatot F; Picquenot JM; Contentin N; Lenain P; Groza L; Lemasle E; Fronville C; Cardinael N; Fontoura ML; Chamseddine A; Brehar O; Stamatoullas A; Leprêtre S; Tilly H; Jardin F
Eur J Haematol; 2014 Jul; 93(1):9-18. PubMed ID: 24520908
[TBL] [Abstract][Full Text] [Related]
12. Skeletal muscle density is an independent predictor of diffuse large B-cell lymphoma outcomes treated with rituximab-based chemoimmunotherapy.
Chu MP; Lieffers J; Ghosh S; Belch A; Chua NS; Fontaine A; Sangha R; Turner RA; Baracos VE; Sawyer MB
J Cachexia Sarcopenia Muscle; 2017 Apr; 8(2):298-304. PubMed ID: 27897411
[TBL] [Abstract][Full Text] [Related]
13. Geriatric nutritional risk index as a prognostic factor in patients with diffuse large B cell lymphoma.
Kanemasa Y; Shimoyama T; Sasaki Y; Hishima T; Omuro Y
Ann Hematol; 2018 Jun; 97(6):999-1007. PubMed ID: 29427185
[TBL] [Abstract][Full Text] [Related]
14. Validation and comparison of prognostic values of GNRI, PNI, and CONUT in newly diagnosed diffuse large B cell lymphoma.
Matsukawa T; Suto K; Kanaya M; Izumiyama K; Minauchi K; Yoshida S; Oda H; Miyagishima T; Mori A; Ota S; Hashimoto D; Teshima T;
Ann Hematol; 2020 Dec; 99(12):2859-2868. PubMed ID: 32970194
[TBL] [Abstract][Full Text] [Related]
15. Clinical impact of prognostic nutritional index in diffuse large B cell lymphoma.
Go SI; Park S; Kang MH; Kim HG; Kim HR; Lee GW
Ann Hematol; 2019 Feb; 98(2):401-411. PubMed ID: 30413902
[TBL] [Abstract][Full Text] [Related]
16. Prognostic nutritional index, a novel biomarker which predicts worse prognosis in diffuse large B cell lymphoma.
He J; Yin H; Xia Y; Wu JZ; Liang JH; Zhu HY; Fan L; Li JY; Wang L; Xu W
Leuk Res; 2021 Nov; 110():106664. PubMed ID: 34271293
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of the psoas muscle index, a parameter of sarcopenia, in patients with diffuse large B-cell lymphoma treated with rituximab-based chemoimmunotherapy.
Iltar U; Sözel H; Sözel YK; Ataş Ü; Yücel OK; Salim O; Aydin F; Undar L
Leuk Lymphoma; 2021 May; 62(5):1098-1106. PubMed ID: 33300380
[TBL] [Abstract][Full Text] [Related]
18. Low Geriatric Nutritional Risk Index Is Associated with Poorer Prognosis in Elderly Diffuse Large B-Cell Lymphoma Patients Unfit for Intensive Anthracycline-Containing Therapy: A Real-World Study.
Chuang TM; Liu YC; Hsiao HH; Wang HC; Du JS; Yeh TJ; Gau YC; Ke YL; Yang CI; Lee CP; Hsu CM; Cho SF
Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579119
[TBL] [Abstract][Full Text] [Related]
19. The Prognostic Impact of Pretreatment Geriatric Nutritional Risk Index in Patients with Diffuse Large B-Cell Lymphoma.
Atas U; Sozel H; Iltar U; Yucel OK; Salim O; Undar L
Nutr Cancer; 2023; 75(2):591-598. PubMed ID: 36343361
[TBL] [Abstract][Full Text] [Related]
20. Relationship Between Preoperative Sarcopenia Status and Immuno-nutritional Parameters in Patients with Early-stage Non-small Cell Lung Cancer.
Shoji F; Matsubara T; Kozuma Y; Haratake N; Akamine T; Takamori S; Katsura M; Toyokawa G; Okamoto T; Maehara Y
Anticancer Res; 2017 Dec; 37(12):6997-7003. PubMed ID: 29187486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
